PRE 14A

PROXY STATEMENT

Company: Bluejay Diagnostics, Inc.
Filed: May 8, 2023
Period of Report: May 5, 2023
Accession Number: 0001213900-23-036987

View Document ↗ View on SEC.gov ↗